Journal of Clinical Gastroenterology and Hepatology Open Access

  • ISSN: 2575-7733
  • Journal h-index: 5
  • Journal CiteScore: 0.63
  • Journal Impact Factor: 0.41
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Pre-operative preparation of a patient with disseminated GIST

14th International Conference on Gastro Education
September 06-07, 2018 London, UK

Anjana Vasudevan

Sri Ramachandra Medical College and Research Institute, India

Posters & Accepted Abstracts: J Clin Gastroenterol Hepatol

Abstract:

Gastrointestinal stromal tumours (GIST) are non-epithelial (mesenchymal) tumours which are derived due to activating mutations of cKIT(a proto-oncogene called CD117) and less commonly platelet-derived growth factor receptor alpha (PDGFRA). The clinical behaviour is variable, and assessment of the malignancy potential is usually based mainly on the size and the proliferation characteristics of the tumour. Complete surgical excision is the treatment of choice for localized GIST. Most GISTs respond to imatinib mesylate, which selectively inhibits both KIT and PDGFRA, and is now considered as the standard systemic therapy for advanced GIST. Here, we present a 68 year old female who was diagnosed with GIST and underwent sleeve gastrectomy with omentectomy and splenectomy in view of diemmination. Subsequently her histopathology reports suggested high grade spindle cell variant of GIST.

Biography :

E-mail:

vasudevan_anjana@hotmail.com